Minoryx Therapeutics is a biopharmaceutical company focused on developing treatments for rare neurological diseases. The company specializes in research and development of therapeutic solutions for conditions such as adrenoleukodystrophy (ALD) and other rare central nervous system disorders.
The company operates in the rare disease pharmaceutical sector, where there is significant unmet medical need and potential for orphan drug designations. Minoryx Therapeutics focuses on advancing drug candidates through clinical development for neurological conditions that currently have limited treatment options. The company remains active in the competitive rare disease therapeutics space, working to bring innovative treatments to patients with rare neurological conditions.
Minoryx Therapeutics has received investment from 1 venture capital firm.
Biopharmaceutical company developing treatments for rare neurological diseases and CNS disorders.
Minoryx Therapeutics has received investment from Asabys Partners. These venture capital firms and investors provide both capital and strategic support.
Minoryx Therapeutics operates in the Biotech sector. Biopharmaceutical company developing treatments for rare neurological diseases and CNS disorders.
